Molecular Analysis of the Short Arm of Chromosome 3 in Small-Cell and Non-Small-Cell Carcinoma of the Lung

TLDR

Previous studies have linked loss of DNA sequences on chromosome 3p to small‑cell lung carcinoma. The authors examined tumor tissue from 42 patients with small‑cell or non‑small‑cell lung carcinoma to detect loss of 3p alleles. They analyzed tumor samples—including biopsy‑derived cell lines, an autopsy specimen, and a lymph‑node excision—to assess 3p allele status. Loss of 3p alleles was found in all heterozygous small‑cell patients, in 4 of 15 non‑small‑cell cases, and persisted before and after chemotherapy, indicating a consistent alteration in small‑cell and a less frequent change in non‑small‑cell lung carcinoma.

Abstract

Previous studies have suggested that the loss of DNA sequences on the short arm of chromosome 3 (3p) is associated with small-cell lung carcinoma. We therefore looked for loss of 3p alleles in tumor tissue from 42 patients with either small-cell or non-small-cell lung carcinoma. All 13 patients with small-cell lung carcinoma who were heterozygous for one or more alleles at 3p in normal tissue had the loss of at least one codominant allele in the tumor tissue. Cell lines of small-cell lung carcinoma from an additional eight patients were homozygous for 3p alleles; this result was significantly different from the predicted frequency of homozygosity. The tumor tissue studied included cell lines of small-cell lung carcinoma obtained from biopsy specimens, an autopsy sample, and an excised lymph node containing tumor cells. Loss of alleles at 3p was observed in tumor samples obtained before and after chemotherapy. Four of 15 evaluable patients with non-small-cell carcinoma of the lung had loss of 3p alleles. We conclude that loss of alleles at 3p is a change found consistently in small-cell lung carcinoma and occasionally in non-small-cell lung carcinoma.